Biopartitioning micellar chromatography with sodium dodecyl sulfate as a pseudo α1-acid glycoprotein to the prediction of protein-drug binding

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 912, Issue , 2013, Pages 50-55

  Hadjmohammadi, Mohammadreza ^a   Salary, Mina ^a  

^a UNIVERSITY OF MAZANDARAN   (Iran)

Author keywords

1 Acid glycoprotein (AGP); Biopartitioning micellar chromatography; Protein drug binding; Sodium dodecyl sulfate (SDS)

Indexed keywords

BINDING AFFINITIES; BIOPARTITIONING MICELLAR CHROMATOGRAPHIES; CONFIDENCE LEVELS; DEVELOPED MODEL; EXPERIMENTAL CONDITIONS; EXPERIMENTAL VALUES; FAST METHODS; IN-VITRO; MICELLAR LIQUID CHROMATOGRAPHY; MICELLAR MOBILE PHASIS; MULTIPLE LINEAR REGRESSIONS; NEUTRAL DRUGS; P-VALUES; PLASMA PROTEIN BINDING; PREDICTIVE ABILITIES; PREDICTIVE ACCURACY; PROTEIN-DRUG BINDING; SDS MICELLES; SECOND-ORDER POLYNOMIAL; SODIUM DODECYL SULFATE; STANDARD DEVIATION; STANDARD ERRORS; VALIDATION RESULTS;

BINDING ENERGY; BIOCHEMISTRY; FORECASTING; GLYCOPROTEINS; LINEAR REGRESSION; LIQUID CHROMATOGRAPHY; MICELLES; PROTEINS; SODIUM; SULFUR COMPOUNDS;

SODIUM SULFATE;

ALPRAZOLAM; ATENOLOL; CARBAMAZEPINE; CHLORPROMAZINE; CIMETIDINE; CLONAZEPAM; DIAZEPAM; DODECYL SULFATE SODIUM; LORAZEPAM; NITRAZEPAM; OROSOMUCOID; OXAZEPAM; PHENYTOIN; PROPRANOLOL; RANITIDINE;

ARTICLE; BIOPARTITIONING MICELLAR CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); CRITICAL MICELLE CONCENTRATION; DRUG PROTEIN BINDING; DRUG RETENTION; ERROR; MICELLAR LIQUID CHROMATOGRAPHY; MICELLE; PKA; PLASMA PROTEIN BINDING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN STRUCTURE; VALIDATION PROCESS;

CHROMATOGRAPHY, LIQUID; OROSOMUCOID; PROTEIN BINDING; SODIUM DODECYL SULFATE;

EID: 84871447491     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.11.020     Document Type: Article

References (43)

1. Krueger-Thiemer E., Buenger P. Chemotherapia 1965, 10(61-73):129.
2. Benet L.Z., Kroetz D.L., Sheiner L.B. The Pharmacological Basis of Therapeutics 1996, 3. McGraw-Hill, New York. G.A. Goodman, Gilman (Eds.).
3. Rowley M., Kulagowski J.J., Watt A.P., Rathbone D., Stevenson G.I., Carling R.W., Baker R., Marshall G.R., Kemp J.A., Foster A.C., Grimwood S., Hargreaves R., Hurley C., Saywell K.L., Tricklebank M.D., Leeson P.D. J. Med. Chem. 1997, 40:4053.
4. Rolan P.E. Br. J. Clin. Pharmacol. 1994, 37:125.
5. Williams K., Lee E. Drugs 1985, 30:333.
6. Jamali F., Mehvar R., Pasutto F.M. J. Pharm. Sci. 1989, 78:695.
7. Schmid K. Plasma Proteins 1975, vol. 1:184. Academic Press, New York.
8. Chrysanthakopoulos M., Giaginis C., Tsantili-Kakoulidou A. J. Chromatogr. A 2010, 1217:5761.
9. Morris J.J., Bruneau P.P. Virtual Screening for Bioactive Compounds 2000, 33. Wiley-VCH Verlag GmbH, Weinheim. H.-J. Boehm, H. Schneider (Eds.).
10. Perhourc F.D.-M., Radouane A., Labat L., Bannwarth B. Pharm. Res. 1995, 12:1535.
11. Pinkerton T.C., Koeplinger K.A. Anal. Chem. 1990, 62:2114.
12. Li F.M., Guo X.J., Qiao M.X., Xiong Z.L., Zhou D.W. Chin. J. Chromatogr. 2004, 22:349.
13. Domenici E., Bertucci C., Salvadori P., Motellier S., Wainer I.W. Chirality 1990, 2:263.
14. Beaudry F., Coutu M., Brown N.K. Biomed. Chromatogr. 1999, 13:401.
15. Allenmark S., Bomgren B., Boren H. J. Chromatogr. 1983, 264:63.
16. Jia H., Yang G., Li Z., Xin P., Zhao Y., Chen Y. J. Chromatogr. A 2007, 1143:88.
17. Wang S., Yang G., Zhang H., Liu H., Li Z. J. Chromatogr. B 2007, 846:329.
18. Escuder-Gilabert L., Molero-Monfort M., Villanueva-Camañas R.M., Sagrado S., Medina-Hernández M.J. J. Chromatogr. B 2004, 807:193.
19. Martínez-Pla J.J., Sagrado S., Villanueva-Camañas R.M., Medina-Hernández M.J. J. Chromatogr. B 2001, 757:89.
20. Quiñones-Torrelo C., Sagrado S., Villanueva-Camañas R.M., Medina-Hernández M.J. J. Chromatogr. B 2001, 761:13.
21. Eriksson M.A.L., Gabrielsson J., Nilsson L.B. J. Pharm. Biomed. Anal. 2005, 38:381.
22. de Jong L.A.A., Uges D.R.A., Franke J.P., Bischoff R. J. Chromatogr. B 2005, 829:1.
23. Parikh H.H., McElwain K., Balasubramanian V., Leung W., Wong D., Morris M.E., Ramanathan M. Pharm. Res. 2000, 17:632.
24. Wu L.P., Chen Y., Wang S.R., Chen C., Ye L.M. Biomed. Chromatogr. 2008, 22:106.
25. Wu L.P., Chen C., Sun C.J., Ye L.M. J. Bioequiv. Availab. 2011, 3:169.
26. Wu L.P., Cui Y., Xiong M.J., Wang S.R., Chen C., Ye L.M. Biomed. Chromatogr. 2008, 22:1243.
27. Chen Y., Wu L.P., Chen C., Ye L.M. Biomed. Chromatogr. 2010, 24:195.
28. Wold S. Technometrics 1978, 20:397.
29. Cramer R.D., Patterson D.E., Bunce J.D. J. Am. Chem. Soc. 1988, 110:5959.
30. Osten D.W. J. Chemometr. 1988, 2:39.
31. The Pharmacological Basis of Therapeutics 2001, McGraw-Hill, New York. 10th ed. A. Goodman Gilman, J.G. Hardman, L.E. Limbird (Eds.).
32. Martindale: The Complete Drug Reference 2009, Pharmaceutical Press, London. 36th ed. S.C. Sweetman (Ed.).
33. Ghasemi J., Saaidpour S. Anal. Chim. Acta 2007, 604:99.
34. Yazdanipour A. J. Iran. Chem. Res. 2009, 2:293.
35. Physicochemical Principles of Pharmacy 2006, Pharmaceutical Press, London. 4th ed. A.T. Florence, D. Attwood (Eds.).
36. Fournier T., Medjoubi-N N., Porquet D. Biochim. Biophys. Acta 2000, 1482:157.
37. Schmid K., Binette J.P. Nature 1961, 190:630.
38. Borgerding M.F., Hinze W.L., Stafford L.D., Fulp G.W., Hamlin W.C. Anal. Chem. 1989, 61:1353.
39. Ruiz-ángel M.J., Carda-Broch S., Torres-Lapasió J.R., García-álvarez-Coque M.C. J. Chromatogr. A 2009, 1216:1798.
40. Shinoda K. Colloidal Surfactants 1963, Academic Press, New York. K. Shinoda, B. Tamamushi, T. Isemura (Eds.).
41. Becher P. J. Colloid Sci. 1962, 17:325.
42. MacKichan J.J. Applied Pharmacokinetics. Principles of Therapeutic Drug Monitoring 1992, Applied Therapeutics, Vancouver. W.E. Evans, J.J. Schentag, W.J. Jusko, M.V. Relling (Eds.).
43. Banker M.J., Clark T.H. Curr. Drug Metab. 2008, 9:854.